Jiangsu Bioperfectus Technologies Co., Ltd. (SHA:688399)
China · Delayed Price · Currency is CNY 67.50
+0.36 (0.54%)
Sep 19, 2025, 2:45 PM CST
SHA:688399 Revenue
Jiangsu Bioperfectus Technologies had revenue of 83.97M CNY in the quarter ending June 30, 2025, a decrease of -2.73%. This brings the company's revenue in the last twelve months to 347.74M, down -11.74% year-over-year. In the year 2024, Jiangsu Bioperfectus Technologies had annual revenue of 349.61M, down -13.29%.
Revenue (ttm)
347.74M
Revenue Growth
-11.74%
P/S Ratio
16.30
Revenue / Employee
593.41K
Employees
592
Market Cap
5.67B
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2024 | 349.61M | -53.57M | -13.29% |
| Dec 31, 2023 | 403.18M | -5.13B | -92.72% |
| Dec 31, 2022 | 5.53B | 2.70B | 94.95% |
| Dec 31, 2021 | 2.84B | 1.10B | 63.19% |
| Dec 31, 2020 | 1.74B | 1.45B | 502.39% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Jiangsu Hengrui Medicine | 30.15B |
| WuXi AppTec | 41.90B |
| Shenzhen Mindray Bio-Medical Electronics | 32.94B |
| Sichuan Biokin Pharmaceutical | 441.19M |
| Shanghai United Imaging Healthcare | 10.98B |
| Zhangzhou Pientzehuang Pharmaceutical., | 10.52B |
| Aier Eye Hospital Group | 21.94B |
| Yunnan Baiyao Group Co.,Ltd | 40.84B |